HighTower Advisors’s Genprex GNPX Stock Holding History

HighTower Advisors’s Portfolio GNPX Stock Details GNPX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1	Closed	-$18K	–	3371
2021 Q3	$18K	Buy	+1	New	+$129K	﹤0.01%	3005

Other funds holding GNPX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

HIP

HUB Investment Partners Austin, Texas $4.18B AUM 24.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

HighTower Advisors's GNPX Position: Q3 2025 in Review

HighTower Advisors sold out of Genprex (GNPX) in Q3 2025, closing a stake of 13 shares — an estimated $3.19K sold.

HighTower Advisors first reported a position in GNPX in Q3 2021 and held it in 6 quarters. The position peaked at $70K in Q3 2021. 13 funds tracked by Wall St. Rank hold GNPX as of Q3 2025.

HighTower Advisors reported no remaining Genprex position as of Q3 2025 after selling out during the quarter.
HighTower Advisors sold 13 Genprex shares in Q3 2025, an estimated $3.19K.
HighTower Advisors first reported a position in Genprex in Q3 2021 and held it in 6 quarters.
HighTower Advisors's Genprex position peaked at $70K in Q3 2021.
13 funds tracked by Wall St. Rank held Genprex as of Q3 2025.

Based on HighTower Advisors's 13F filing for Q3 2025, filed 7 Nov 2025.